China Resources Pharma AGM approves resolutions, board changes announced

China Resources Pharmaceutical Group Limited announced the results of its Annual General Meeting (AGM) held on May 23, 2025, where all proposed resolutions were passed. Key approvals included the adoption of audited financial statements, the declaration of a final dividend of RMB0.052 per share for the year ended December 31, 2024, and the re-election of Mdm. Guo Wei and Mr. Guo Chuan as non-executive directors. Mr. Fu Tingmei and Mr. Zhang Kejian were re-elected as independent non-executive directors, and Mdm. Chiu Mun Wai and Mr. Shi Luwen were newly elected as independent non-executive directors. The company also secured mandates to repurchase shares and issue new shares.